Page last updated: 2024-08-24

simendan and Acute Disease

simendan has been researched along with Acute Disease in 91 studies

Research

Studies (91)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	47 (51.65)	29.6817
2010's	42 (46.15)	24.3611
2020's	2 (2.20)	2.80

Authors

Authors	Studies
Chen, ZJ; Cheng, YQ; Li, ZS; Liu, C; Pan, T; Sun, YH; Wang, DJ; Wang, K; Zhang, H; Zhang, HT	1
Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML	1
Hao, Y; Huang, S; Jia, L; Li, X; Ma, Y; Mao, Y; Qiu, J; Wang, M	1
Altenberger, J; Gustafsson, F; Harjola, VP; Karason, K; Kindgen-Milles, D; Kivikko, M; Malfatto, G; Papp, Z; Parissis, J; Pollesello, P; Pölzl, G; Tschöpe, C	1
Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L	1
Gong, SG; He, J; Jiang, R; Liu, JM; Luo, CJ; Qiu, HL; Wang, L; Wu, WH; Yuan, P; Zhang, R; Zhao, QH	1
Chen, D; Matter, A; Sivakumar, N; Teneggi, V	1
Kleinsasser, A; Knotzer, H; Kotzinger, O; Poidinger, B; Rützler, K; Zierer, A	1
Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH	1
Bouchez, S; Fedele, F; Giannakoulas, G; Gustafsson, F; Harjola, VP; Karason, K; Kivikko, M; Oliva, F; Papp, Z; Parissis, J; Pollesello, P; Pölzl, G; Tschöpe, C; von Lewinski, D	1
Bergounioux, J; Essid, A; Haegy, I; Josseran, L; Mbieleu, B; Sumanaru, D	1
Li, J; Li, Y; Wang, XY; Yang, F; Yang, J; Yang, ZY; Yuan, P	1
Alici, H; Cakici, M; Davutoglu, V; Ercan, S; Kus, E; Sari, I	1
Dipchand, AI; Mohseni-Bod, H; Tosoni, A	1
Bacaksiz, A; Erdogan, E; Ergelen, M; Erturk, M; Karakurt, H; Sonmez, O; Tasal, A; Turfan, M; Uyarel, H; Vatankulu, MA	1
Pollesello, P	1
Chivite, D; Corbella, X; Formiga, F	1
Makris, D; Papanikolaou, J; Tsolaki, V; Zakynthinos, E	1
Guo, M; Jia, Z; Liang, HQ; Song, Y; Zhang, LY; Zhang, YQ	1
Ben-Gal, T; Buerke, M; Comín-Colet, J; Fedele, F; Karavidas, A; Kivikko, M; Nieminen, MS; Parissis, J; Pollesello, P; Severino, P; Wikström, G	1
Duvall, E; Haavisto, M; Kentala, R; Knuuti, J; Levijoki, J; Nyman, L; Pietilä, M; Roivainen, A; Saraste, A; Saukko, P; Saunavaara, V; Savunen, T; Stark, C; Strandberg, M; Tarkia, M; Teräs, M; Tolvanen, T; Vähäsilta, T	1
Alvarez, J; Brito, D; Farmakis, D; Fedele, F; Fonseca, C; Gal, TB; Gordon, AC; Gotsman, I; Grossini, E; Guarracino, F; Harjola, VP; Hellman, Y; Heunks, L; Ivancan, V; Karavidas, A; Kivikko, M; Lomivorotov, V; Longrois, D; Masip, J; Metra, M; Morelli, A; Nikolaou, M; Papp, Z; Parissis, J; Parkhomenko, A; Poelzl, G; Pollesello, P; Ravn, HB; Rex, S; Ricksten, SE; Riha, H; Schwinger, RHG; Vrtovec, B; Yilmaz, MB; Zielinska, M	1
Andersen, GØ; Bjørnerheim, R; Eritsland, J; Husebye, T	1
de Albernaz Muniz, RZ; de March Ronsoni, R; Feijó, RV; Filho, WJ; Melo, LH; Moro, A; Schwingel, FL; Weber, S	1
Harjola, VP; Lassus, J; Melin, J; Nieminen, MS; Peuhkurinen, K; Rossinen, J; Siirila-Waris, K	1
Bagshaw, SM; Bradford, C; Delaney, A; Lee, R; McCaffrey, J	1
Bistola, V; Farmakis, D; Filippatos, G; Iliodromitis, EK; Kremastinos, DT; Paraskevaidis, IA; Parissis, JT	1
Cleland, JG; Cohen-Solal, A; Filippatos, GS; Huang, B; Mebazaa, A; Nieminen, MS; Padley, RJ; Salon, JE; Thakkar, R	1
Beyan, C; Ifran, A; Kaptan, K	1
Abreu-Lima, C; Amorim, S; Damasceno, A; Ferreira, J; Ferreira, R; Fonseca, C; Ilídio-Moreira, J; Lousada, N; Martins-de-Campos, J; Oliveira-Soares, A; Rabaçal, C; Seabra-Gomes, R; Silva-Cardoso, J	1
Chay Woodward, T; de Lissovoy, G; Fraeman, K; Salon, J; Sterz, R	1
Althabe, M; Balestrini, M; Chang, AC; Charroqui, A; Landry, LM; Lataza, E; Magliola, R; Moreno, G; Salgado, G; Vassallo, JC	1
Karayiannis, G; Kirlidis, TT; Skoularigis, J; Triposkiadis, F; Tsaknakis, KT; Tsaknakis, TK	1
Ambrosio, G; De Maria, R; Di Lenarda, A; Fedele, F; Gabrielli, D; Metra, M; Oliva, F; Perna, G; Senni, M	1
Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V	1
Despas, F; Franchitto, N; Galinier, M; Labrunee, M; Pathak, A; Senard, JM; Trouillet, C	1
Grande, DB; Hidalgo, RL; Morales, SC; Moyano, AP	1
Omerovic, E; Swedberg, K; Waagstein, F	1
Busani, S; Cobelli, M; Girardis, M; Pasetto, A; Rinaldi, L; Severino, C	1
Campia, U; Gheorghiade, M; Nodari, S	1
Ata, N; Birdane, A; Cavuşoğlu, Y; Demirüstü, C; Göktekin, Ö; Görenek, B; Tek, M; Ünalır, A	1
Bongo, AS; Lazzero, M; Lupi, A; Rognoni, A; Rognoni, G	1
Böhm, M; Cai, D; Cohen Solal, A; Filippatos, GS; Huang, B; Kivikko, M; Link, A; Mebazaa, A; Nieminen, MS; Padley, RJ; Salem, R	1
Picker, O; Schober, P; Schwarte, LA; Schwartges, I; Thomas, K	1
Beggino, C; Caimmi, PP; Crosio, E; Giustini, G; Grossini, E; Kapetanakis, EI; Micalizzi, E; Molinari, C; Reposo, G; Vacca, G	1
Brasolin, B; Bruno, N; Caira, C; D'Ambrosi, A; Fedele, F; Mancone, M	1
Gautreux Minaya, S; Lobo Martínez, P; Oulego Erroz, I; Rodríguez Fernández, LM	1
Bellmann, R; Bertocchi, C; Bijuklic, K; Dunzendorfer, S; Hasslacher, J; Joannidis, M; Kountchev, J	1
Jovicić, B; Kosutić, J; Nikolić, L; Prijić, S; Rakić, S; Stajević, M; Vukomanović, V	1
Amir, O; Zafrir, B	1
Albayrak, A; Aydin, A; Bayir, Y; Cadirci, E; Ferah, I; Halici, Z; Karakus, E; Odaci, E; Unal, D	1
Cai, D; Cohen-Solal, A; Deye, N; Kivikko, M; Laribi, S; Laterre, PF; Mebazaa, A; Nikolaou, M; Parissis, J; Paugam-Burtz, C; Poder, P; Pohjanjousi, P; Seronde, MF; Yilmaz, MB	1
Andersen, GØ; Arnesen, H; Bjørnerheim, R; Eritsland, J; Husebye, T; Mangschau, A; Müller, C; Sandvik, L; Seljeflot, I	1
Coats, AJ	1
Andrejevs, N; Golikov, AP; Kobalava, ZD; Laine, T; Lazebnik, LB; Lehtonen, LA; Lie, KI; Moiseyev, VS; Nieminen, MS; Põder, P; Ruda, MY	1
Young, JB	1
Teerlink, JR	2
Erhardt, L; Mebazaa, A	1
Erhardt, LR	1
Innes, CA; Wagstaff, AJ	1
Kleber, FX; Lehtonen, LA; Sonntag, S; Sundberg, S	1
Graham, CA	1
Barretto, AC; Canaviera, R; Follador, W; Martins, ML; Oliveira, MT; Scipioni, A; Tsuji, RL	1
Colucci, WS; Maytin, M	1
Gheorghiade, M; Mebazaa, A; Teerlink, JR	1
Barraud, D; Mebazaa, A; Welschbillig, S	1
Cardoso, JS; Follath, F; Franco, F	1
Earl, GL; Fitzpatrick, JT	1
Adamopoulos, S; Farmakis, D; Filippatos, G; Kremastinos, D; Paraskevaidis, I; Parissis, JT	1
Akhter, MW; Ng, TM	1
Atar, D; Hodt, A; Steine, K	1
Delgado, JF	1
Munger, MA	1
Feres, GA; Garcia, JA; Hansen, MH; Holanda, GS; Salluh, JI; Simvoulidis, LF; Soares, M; Souza, RC; Toscano, L	1
De Keulenaer, B; Powell, BP	1
Cohen-Solal, A; Kivikko, M; Kleber, FX; Mebazaa, A; Nieminen, MS; Packer, M; Padley, RJ; Pocock, SJ; Põder, P; Thakkar, R	1
Brimioulle, S; Collart, F; Fesler, P; Gariboldi, V; Giorgi, R; Gouin, F; Guieu, R; Kerbaul, F; Mekkaoui, C	1
D'Orio, V; Ghuysen, A; Harstein, G; Lambermont, B	1
Carbajosa-Dalmau, J; Carrasco-Moreno, R; Climent-Payá, V; Diéguez-Zaragoza, S; Fernández-Cañadas, J; Laghzaoui, F; Llorens-Soriano, P; Murcia-Zaragoza, J	1
Butler, J; Giamouzis, G; Giannakoulas, G	1
Boldt, J; Isgro, F; Kiessling, AH; Lehmann, A; Thaler, E; Zeitler, C	1
Powell, BP; Simes, D	1
Erdem, A; Karadas, F; Tandogan, I; Turgut, OO; Yalta, K; Yilmaz, A; Yilmaz, MB; Yontar, C	1
Damman, K; Voors, AA	1
Felker, GM; Petersen, JW	1
Khouadja, H; Mebazaa, A; Rezlan, E; Tavares, M; Vostroknoutova, I	1
Archan, S; Toller, W	1
Andrade, AC; Mebazaa, A; Tavares, M	1
Garrido Bravo, IP; Manzano-Fernández, S; Marín, F; Pascual Figal, DA	1

Reviews

33 review(s) available for simendan and Acute Disease

Article	Year
Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis. Life sciences, 2017, Sep-01, Volume: 184 Topics: Acute Disease; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome; Vasodilator Agents	2017
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications. Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:3 Topics: Acute Disease; Cardiotonic Agents; Chronic Disease; Clinical Decision-Making; Congresses as Topic; Databases, Factual; Heart Failure; Humans; Myocardial Contraction; Patient Selection; Recovery of Function; Risk Factors; Simendan; Treatment Outcome; Vasodilation; Vasodilator Agents	2018
Drugs' development in acute heart failure: what went wrong? Heart failure reviews, 2018, Volume: 23, Issue:5 Topics: Acute Disease; Cardiotonic Agents; Drug Approval; Drug Development; Heart Failure; Humans; Natriuretic Peptide, Brain; Simendan	2018
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application. Cardiovascular drugs and therapy, 2018, Volume: 32, Issue:6 Topics: Acute Disease; Cardiotonic Agents; Chronic Disease; Congresses as Topic; Evidence-Based Medicine; Heart Failure; Humans; Kidney; Myocardial Contraction; Recovery of Function; Simendan; Time Factors; Treatment Outcome; Vasodilator Agents	2018
The use of levosimendan in children with cancer with severe acute cardiac dysfunction: case series and a review of the literature. Cardiology in the young, 2014, Volume: 24, Issue:3 Topics: Acute Disease; Antineoplastic Agents; Cardiotonic Agents; Child, Preschool; Female; Heart Failure; Humans; Hydrazones; Leukemia, Myeloid, Acute; Neuroblastoma; Pyridazines; Severity of Illness Index; Simendan	2014
BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction. Emergency medicine journal : EMJ, 2013, Volume: 30, Issue:12 Topics: Acute Disease; Cardiotonic Agents; Evidence-Based Emergency Medicine; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Treatment Outcome	2013
[Organ-protection therapy. A new therapeutic approach for acute heart failure?]. Medicina clinica, 2014, Volume: 142 Suppl 1 Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan	2014
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. International journal of cardiology, 2016, Nov-01, Volume: 222 Topics: Acute Disease; Anti-Arrhythmia Agents; Cardiotonic Agents; Clinical Trials as Topic; Expert Testimony; Heart; Heart Failure; Humans; Hydrazones; Muscle Contraction; Pyridazines; Simendan; Treatment Outcome	2016
Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials. International journal of cardiology, 2010, Feb-04, Volume: 138, Issue:3 Topics: Acute Disease; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Severity of Illness Index; Simendan	2010
[Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment]. Giornale italiano di cardiologia (2006), 2009, Volume: 10, Issue:7 Topics: Acute Disease; Algorithms; Calcium; Cardiotonic Agents; Clinical Trials as Topic; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Patient Selection; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Severity of Illness Index; Simendan; Treatment Outcome	2009
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart failure reviews, 2009, Volume: 14, Issue:4 Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents	2009
Levosimendan: from basic science to clinical trials. Recent patents on cardiovascular drug discovery, 2011, Volume: 6, Issue:1 Topics: Acute Disease; Animals; Calcium Channels; Cardiovascular Agents; Chronic Disease; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Oxygen Consumption; Potassium Channels; Pyridazines; Simendan; Translational Research, Biomedical; Treatment Outcome; Ventricular Function	2011
Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives. The Israel Medical Association journal : IMAJ, 2012, Volume: 14, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hydrazones; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridazines; Simendan	2012
New therapeutic choices in the management of acute congestive heart failure. Reviews in cardiovascular medicine, 2001, Volume: 2 Suppl 2 Topics: Acute Disease; Heart Failure; Humans; Hydrazones; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Quinolones; Simendan; Treatment Outcome; Vasodilator Agents	2001
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. American heart journal, 2003, Volume: 145, Issue:2 Suppl Topics: Acute Disease; Drug Approval; Dyspnea; Forecasting; Heart Failure; Hospitalization; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Pyridines; Randomized Controlled Trials as Topic; Severity of Illness Index; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents	2003
The development of new medical treatments for acute decompensated heart failure. Heart failure monitor, 2002, Volume: 2, Issue:4 Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Heart Failure; Hemodynamics; Humans; Hydrazones; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Placebos; Pyridazines; Pyridines; Randomized Controlled Trials as Topic; Receptors, Endothelin; Simendan; Tetrazoles; Time Factors; Vasodilator Agents	2002
Levosimendan: a new dual-action drug in the treatment of acute heart failure. International journal of clinical practice, 2003, Volume: 57, Issue:5 Topics: Acute Disease; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Analysis; Treatment Outcome	2003
Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure? Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4 Suppl 2 Topics: Acute Disease; Calcium; Calcium Channels, L-Type; Cardiac Output; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Simendan; Vascular Resistance; Vasodilator Agents	2003
Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs, 2003, Volume: 63, Issue:23 Topics: Acute Disease; Animals; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan	2003
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department. Emergency medicine Australasia : EMA, 2004, Volume: 16, Issue:1 Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Critical Illness; Developed Countries; Diuretics; Emergency Service, Hospital; Emergency Treatment; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Oxygen Inhalation Therapy; Patient Selection; Pulmonary Edema; Pyridazines; Pyridines; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents	2004
Cardioprotection: a new paradigm in the management of acute heart failure syndromes. The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A Topics: Acute Disease; Animals; Cardiotonic Agents; Cells, Cultured; Heart Failure; Humans; Hydrazones; Hydrogen Peroxide; Myocytes, Cardiac; Oxidative Stress; Pyridazines; Rats; Simendan; Syndrome	2005
Pharmacology of new agents for acute heart failure syndromes. The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Pyridazines; Pyridines; Simendan; Syndrome; Tetrazoles; Tolvaptan; Vasodilator Agents	2005
Randomized clinical trials with levosimendan. The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome	2005
European experience on the practical use of levosimendan in patients with acute heart failure syndromes. The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A Topics: Acute Disease; Cardiotonic Agents; Europe; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome	2005
Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11 Topics: Acute Disease; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Treatment Outcome	2005
Levosimendan for the treatment of acute heart failure syndromes. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:15 Topics: Acute Disease; Animals; Heart Failure; Humans; Hydrazones; Pyridazines; Radiography; Simendan; Syndrome	2005
Levosimendan: dual mechanisms for acute heart failure...and beyond? Minerva cardioangiologica, 2005, Volume: 53, Issue:6 Topics: Acute Disease; Calcium; Cardiac Output; Clinical Trials as Topic; Heart Failure; Humans; Hydrazones; Pulmonary Wedge Pressure; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome; Vasodilator Agents	2005
[Medical and ventilatory treatment of acute heart failure]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Mar-09, Volume: 126, Issue:6 Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents	2006
[Levosimendan in acute heart failure: past, present and future]. Revista espanola de cardiologia, 2006, Volume: 59, Issue:4 Topics: Acute Disease; Cardiac Output, Low; Cardiotonic Agents; Clinical Trials as Topic; Forecasting; Humans; Hydrazones; Pyridazines; Simendan	2006
Inotropes in the management of acute heart failure. Critical care medicine, 2008, Volume: 36, Issue:1 Suppl Topics: Acute Disease; Cardiac Myosins; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydrazones; Patient Selection; Pyridazines; Simendan	2008
New pharmacologic therapies for acute heart failure. Critical care medicine, 2008, Volume: 36, Issue:1 Suppl Topics: Acute Disease; Adenosine; Adenosine Triphosphatases; Antidiuretic Hormone Receptor Antagonists; Cardiac Myosins; Cardiotonic Agents; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Natriuretic Peptides; Pyridazines; Simendan	2008
Levosimendan: current status and future prospects. Current opinion in anaesthesiology, 2008, Volume: 21, Issue:1 Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Postoperative Complications; Pyridazines; Shock, Septic; Simendan; Ventricular Dysfunction, Right	2008
Levosimendan use in several scenarios of acute heart failure. Arquivos brasileiros de cardiologia, 2008, Volume: 90, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Contraindications; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypotension; Ischemia; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Syndrome; Vasodilator Agents	2008

Trials

17 trial(s) available for simendan and Acute Disease

Article	Year
Levosimendan and nesiritide as a combination therapy in patients with acute heart failure. The American journal of the medical sciences, 2015, Volume: 349, Issue:5 Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Mortality; Natriuretic Peptide, Brain; Patient Readmission; Pyridazines; Severity of Illness Index; Simendan; Treatment Outcome	2015
Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure. European heart journal. Acute cardiovascular care, 2018, Volume: 7, Issue:4 Topics: Acute Disease; Aged; Blood Flow Velocity; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography, Doppler, Color; Electrocardiography; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydrazones; Infusions, Intravenous; Male; Mitral Valve; Pyridazines; Reproducibility of Results; Simendan; ST Elevation Myocardial Infarction; Systole; Time Factors; Treatment Outcome; Ventricular Function, Left	2018
Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. International journal of cardiology, 2010, Feb-18, Volume: 139, Issue:1 Topics: Acute Disease; Aged; Biomarkers; Cardiotonic Agents; Chronic Disease; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Heart Function Tests; Humans; Hydrazones; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Predictive Value of Tests; Pyridazines; Sensitivity and Specificity; Simendan; Ultrasonography	2010
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. European journal of heart failure, 2009, Volume: 11, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cause of Death; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Survival Rate; Treatment Outcome	2009
Effectiveness and safety of levosimendan in clinical practice. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2009, Volume: 28, Issue:2 Topics: Acute Disease; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Systole; Vasodilator Agents	2009
The costs of treating acute heart failure: an economic analysis of the SURVIVE trial. Journal of medical economics, 2008, Volume: 11, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Female; Health Expenditures; Heart Failure; Humans; Hydrazones; Length of Stay; Male; Middle Aged; Patient Admission; Pyridazines; Simendan	2008
[Levosimendan, a new inotropic drug: experience in children with acute heart failure]. Archivos argentinos de pediatria, 2009, Volume: 107, Issue:2 Topics: Acute Disease; Adolescent; Cardiac Output, Low; Cardiotonic Agents; Child; Child, Preschool; Female; Humans; Hydrazones; Infant; Male; Prospective Studies; Pyridazines; Simendan	2009
The influence of beta-blockade on the hemodynamic effects of levosimendan in elderly (>or= 70 years) patients with acutely decompensated systolic heart failure. International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:7 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Heart Failure, Systolic; Hemodynamics; Humans; Hydrazones; Pyridazines; Simendan	2009
Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording. Acute cardiac care, 2010, Volume: 12, Issue:1 Topics: Acute Disease; Cardiotonic Agents; Drug Monitoring; Echocardiography; Electromyography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Microelectrodes; Middle Aged; Plethysmography; Pyridazines; Simendan; Single-Blind Method; Statistics, Nonparametric; Sympathetic Nervous System; Treatment Outcome	2010
[Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2010, Volume: 38, Issue:5 Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Parenteral; Male; Middle Aged; Pyridazines; Risk Factors; Simendan; Tachycardia, Ventricular; Ventricular Premature Complexes	2010
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial. Critical care medicine, 2011, Volume: 39, Issue:5 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; International Cooperation; Kaplan-Meier Estimate; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome	2011
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study. European journal of heart failure, 2013, Volume: 15, Issue:5 Topics: Acute Disease; Aged; Cardiotonic Agents; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Norway; Percutaneous Coronary Intervention; Pyridazines; Simendan; Treatment Outcome	2013
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). European heart journal, 2002, Volume: 23, Issue:18 Topics: Acute Disease; Aged; Analysis of Variance; Cardiotonic Agents; Double-Blind Method; Drug Evaluation; Endpoint Determination; Female; Heart Failure; Humans; Hydrazones; Hypotension; Male; Myocardial Infarction; Prospective Studies; Pyridazines; Risk Factors; Safety; Simendan; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left	2002
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. Journal of the American College of Cardiology, 2004, Jun-16, Volume: 43, Issue:12 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Volume; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Diastole; Double-Blind Method; Female; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Pyridazines; Simendan; Systole; Treatment Outcome; Vasodilation; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure	2004
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA, 2007, May-02, Volume: 297, Issue:17 Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Analysis	2007
[Clinical experience with levosimendan in the emergency department of a tertiary care hospital]. Revista espanola de cardiologia, 2007, Volume: 60, Issue:8 Topics: Acute Disease; Aged; Cardiotonic Agents; Emergency Service, Hospital; Emergency Treatment; Female; Heart Failure; Humans; Hydrazones; Male; Prospective Studies; Pyridazines; Simendan	2007
Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6 Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Male; Middle Aged; Pyridazines; Simendan; Urination	2007

Other Studies

41 other study(ies) available for simendan and Acute Disease

Article	Year
The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis. BMC anesthesiology, 2022, 05-03, Volume: 22, Issue:1 Topics: Acute Disease; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Hydrazones; Male; Myocardial Infarction; Postoperative Complications; Propensity Score; Prospective Studies; Pyridazines; Simendan; Ventricular Septal Rupture	2022
Levosimendan with other inotropes or vasopressors: Should you combine them? The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents	2020
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2017, Volume: 36, Issue:9 Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan	2017
Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension. The clinical respiratory journal, 2018, Volume: 12, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Cardiotonic Agents; China; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Injections, Intravenous; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Pyridazines; Receptors, Calcium-Sensing; Simendan; Survival Rate; Treatment Outcome; Ventricular Function, Right; Young Adult	2018
Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass. Journal of cardiothoracic and vascular anesthesia, 2019, Volume: 33, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Retrospective Studies; Simendan; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents; Vasopressins	2019
Treatments targeting inotropy. European heart journal, 2019, 11-21, Volume: 40, Issue:44 Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea	2019
Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy. Pediatric cardiology, 2019, Volume: 40, Issue:3 Topics: Acute Disease; Adult; Cardiomyopathies; Cardiotonic Agents; Heart Failure; Humans; Lactic Acid; Male; Muscular Dystrophy, Duchenne; Natriuretic Peptide, Brain; Pneumonia; Simendan	2019
The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP. European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:9 Topics: Acute Disease; Aged; Aged, 80 and over; Calcium; Cardiotonic Agents; Female; Heart Failure; Humans; Hypokalemia; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Potassium; Simendan; Stroke Volume; Ventricular Function, Left	2019
Rapid recovery from acute myocarditis under levosimendan treatment: report of two cases. Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:2 Topics: Acute Disease; Adult; Cardiotonic Agents; Echocardiography; Humans; Hydrazones; Male; Middle Aged; Myocarditis; Pyridazines; Simendan	2013
Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure. Journal of cardiology, 2014, Volume: 63, Issue:6 Topics: Acute Disease; Aged; Cardiotonic Agents; Disease Progression; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Pyridazines; Retrospective Studies; Simendan	2014
Drug discovery and development for acute heart failure drugs: are expectations too high? International journal of cardiology, 2014, Mar-01, Volume: 172, Issue:1 Topics: Acute Disease; Cardiotonic Agents; Clinical Trials as Topic; Drug Discovery; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Urea	2014
Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure. International journal of cardiology, 2014, Oct-20, Volume: 176, Issue:3 Topics: Acute Disease; Adult; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hydrazones; Injections, Intravenous; Myocardial Contraction; Pyridazines; Simendan; Subarachnoid Hemorrhage; Time Factors	2014
Pharmaco-economics of levosimendan in cardiology: a European perspective. International journal of cardiology, 2015, Nov-15, Volume: 199 Topics: Acute Disease; Algorithms; Cardiology; Cardiotonic Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Europe; Heart Failure; Hospitalization; Humans; Hydrazones; Length of Stay; Models, Economic; Mortality; Pyridazines; Quality of Life; Simendan	2015
Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion. Heart (British Cardiac Society), 2016, Volume: 102, Issue:6 Topics: Acute Disease; Animals; Cardiotonic Agents; Coronary Occlusion; Diastole; Disease Models, Animal; Follow-Up Studies; Hydrazones; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Pyridazines; Simendan; Stroke Volume; Swine; Systole; Ventricular Function, Left; Ventricular Remodeling	2016
The use of Levosimendan for myocardiopathy due to acute Chagas' disease. International journal of cardiology, 2009, Aug-14, Volume: 136, Issue:2 Topics: Acute Disease; Cardiotonic Agents; Chagas Cardiomyopathy; Humans; Hydrazones; Myocarditis; Pyridazines; Simendan	2009
The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study. Acute cardiac care, 2008, Volume: 10, Issue:4 Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Catecholamines; Female; Finland; Heart Failure; Hospital Mortality; Humans; Hydrazones; Length of Stay; Male; Middle Aged; Pyridazines; Retrospective Studies; Risk Factors; Simendan; Statistics, Nonparametric; Treatment Outcome	2008
Do levosimendan have an adverse effect on platelet function? International journal of cardiology, 2010, Oct-29, Volume: 144, Issue:3 Topics: Acute Disease; Blood Platelets; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Meta-Analysis as Topic; Platelet Aggregation; Pyridazines; Randomized Controlled Trials as Topic; Simendan	2010
[Use of levosimendan in acute heart failure and its effect on renal function]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2009, Volume: 29, Issue:6 Topics: Acute Disease; Aged; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Kidney; Male; Pyridazines; Simendan	2009
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence? European journal of heart failure, 2010, Volume: 12, Issue:4 Topics: Acute Disease; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan	2010
Levosimendan in cardiac failure after subarachnoid hemorrhage. The Journal of trauma, 2010, Volume: 68, Issue:5 Topics: Acute Disease; Adult; Cardiotonic Agents; Critical Care; Embolization, Therapeutic; Female; Heart Failure; Humans; Hydrazones; Italy; Myocardial Stunning; Off-Label Use; Patient Selection; Pyridazines; Radiography; Simendan; Stroke Volume; Subarachnoid Hemorrhage; Treatment Outcome; Ventricular Function, Left	2010
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events? Current heart failure reports, 2010, Volume: 7, Issue:3 Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea	2010
The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia. Intensive care medicine, 2011, Volume: 37, Issue:4 Topics: Acute Disease; Adenosine Triphosphate; Animals; Dogs; Glyburide; Hemodynamics; Hydrazones; Hypoglycemic Agents; Hypoxia; Metabolism; Microcirculation; Models, Animal; Pyridazines; Simendan; Vasodilator Agents	2011
Management of acute cardiac failure by intracoronary administration of levosimendan. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Blood Pressure; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydrazones; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pyridazines; Simendan; Vascular Resistance; Ventricular Function, Left	2011
Cost-effectiveness of levosimendan in patients with acute heart failure. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:4 Topics: Acute Disease; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Patient Readmission; Pyridazines; Retrospective Studies; Simendan; Survival Rate	2011
Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension. Pediatric cardiology, 2011, Volume: 32, Issue:7 Topics: Acute Disease; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuresis; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Follow-Up Studies; Glycogen Storage Disease Type I; Heart Failure; Humans; Hydrazones; Hypertension; Infusions, Intravenous; Kidney Failure, Chronic; Male; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume	2011
Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Critical care (London, England), 2011, Jul-12, Volume: 15, Issue:4 Topics: Acute Disease; Aged; Aged, 80 and over; Austria; Cardiotonic Agents; Female; Flow Cytometry; Heart Failure; Humans; Hydrazones; In Vitro Techniques; Male; Middle Aged; Neutrophils; Prospective Studies; Pyridazines; Reactive Oxygen Species; Shock, Septic; Simendan	2011
[Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Vojnosanitetski pregled, 2011, Volume: 68, Issue:11 Topics: Acute Disease; Adolescent; Cardiotonic Agents; Child, Preschool; Dobutamine; Heart Failure; Humans; Hydrazones; Male; Milrinone; Pyridazines; Simendan	2011
Beneficial pharmacological effects of levosimendan on antioxidant status of acute inflammation induced in paw of rat: involvement in inflammatory mediators. Basic & clinical pharmacology & toxicology, 2013, Volume: 112, Issue:3 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Disease Models, Animal; Edema; Hydrazones; Inflammation Mediators; Lower Extremity; Male; Pyridazines; Rats; Rats, Wistar; Simendan	2013
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. European heart journal, 2013, Volume: 34, Issue:10 Topics: Acute Disease; Aged; Alkaline Phosphatase; Cardiotonic Agents; Cholestasis; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Liver Diseases; Liver Function Tests; Male; Prognosis; Prospective Studies; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Transaminases	2013
Positive inotropy for acute heart failure complicating myocardial infarction. European heart journal, 2002, Volume: 23, Issue:18 Topics: Acute Disease; Cardiotonic Agents; Clinical Trials as Topic; Drug Evaluation; Heart Failure; Humans; Hydrazones; Myocardial Infarction; Pyridazines; Simendan; Treatment Outcome; Ventricular Dysfunction, Left	2002
[Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine]. Arquivos brasileiros de cardiologia, 2005, Volume: 85, Issue:1 Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Health Care Costs; Heart Failure; Hospital Costs; Humans; Hydrazones; Length of Stay; Pyridazines; Simendan	2005
Management of acute decompensated heart failure: treatment, controversy, and future directions. Pharmacotherapy, 2006, Volume: 26, Issue:8 Pt 2 Topics: Acute Disease; Atrial Natriuretic Factor; Diuretics; Guideline Adherence; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Peptide Fragments; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents	2006
Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity. International journal of cardiology, 2007, Jun-12, Volume: 118, Issue:3 Topics: Acute Disease; Adult; Anthracyclines; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Pyridazines; Simendan; Treatment Outcome	2007
Levosimendan: a new option in acute septic cardiac failure? Emergency medicine Australasia : EMA, 2007, Volume: 19, Issue:2 Topics: Acute Disease; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Pyridazines; Sepsis; Simendan	2007
Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Critical care medicine, 2007, Volume: 35, Issue:8 Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Hydrazones; Hypertension, Pulmonary; Pulmonary Circulation; Pulmonary Embolism; Pyridazines; Random Allocation; Respiration; Simendan; Swine; Ventricular Dysfunction, Right	2007
Levosimendan: right for the right ventricle? Critical care medicine, 2007, Volume: 35, Issue:8 Topics: Acute Disease; Animals; Cardiotonic Agents; Hydrazones; Pulmonary Embolism; Pyridazines; Shock, Cardiogenic; Simendan; Swine; Ventricular Dysfunction, Right	2007
A struggle to SURVIVE: to abandon or not to abandon levosimendan? Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:5 Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Rate; Treatment Outcome	2007
Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. European journal of anaesthesiology, 2008, Volume: 25, Issue:3 Topics: Acute Disease; Aged; Anti-Arrhythmia Agents; Blood Pressure; Case-Control Studies; Catecholamines; Cohort Studies; Coronary Artery Bypass; Emergencies; Female; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Length of Stay; Male; Middle Aged; Monitoring, Intraoperative; Myocardial Ischemia; Myocardial Revascularization; Pyridazines; Respiration, Artificial; Retrospective Studies; Shock, Cardiogenic; Simendan; Survival Rate; Vascular Resistance	2008
Levosimendan in acute pulmonary embolism. Anaesthesia and intensive care, 2007, Volume: 35, Issue:5 Topics: Acute Disease; Aged; Cardiotonic Agents; Humans; Hydrazones; Male; Pulmonary Artery; Pulmonary Embolism; Pyridazines; Simendan	2007
Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al." Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6 Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Pyridazines; Simendan	2007
[Is there a role for levosimendan in hospital emergency departments?]. Revista espanola de cardiologia, 2008, Volume: 61, Issue:5 Topics: Acute Disease; Cardiotonic Agents; Emergency Service, Hospital; Emergency Treatment; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan	2008